NCM Capital Management’s iShares MSCI USA Quality Factor ETF QUAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$756K Hold
3,939
0.27% 89
2025
Q4
$782K Buy
3,939
+100
+3% +$19.6K 0.29% 86
2025
Q3
$747K Hold
3,839
0.29% 83
2025
Q2
$702K Hold
3,839
0.29% 82
2025
Q1
$656K Hold
3,839
0.3% 85
2024
Q4
$684K Hold
3,839
0.31% 79
2024
Q3
$688K Hold
3,839
0.33% 76
2024
Q2
$656K Hold
3,839
0.34% 75
2024
Q1
$631K Hold
3,839
0.35% 75
2023
Q4
$565K Hold
3,839
0.34% 76
2023
Q3
$506K Hold
3,839
0.36% 77
2023
Q2
$518K Hold
3,839
0.36% 79
2023
Q1
$476K Sell
3,839
-1,401
-27% -$168K 0.36% 81
2022
Q4
$597K Sell
5,240
-531
-9% -$60.2K 0.39% 76
2022
Q3
$600K Hold
5,771
0.45% 72
2022
Q2
$645K Hold
5,771
0.45% 72
2022
Q1
$777K Buy
+5,771
New +$766K 0.49% 67

Other funds holding QUAL

NCM Capital Management's QUAL Position: Q1 2026 in Review

NCM Capital Management held its iShares MSCI USA Quality Factor ETF (QUAL) position steady in Q1 2026 at 3,939 shares worth $756K. The position accounts for 0.27% of the portfolio, ranked #89.

NCM Capital Management first reported a position in QUAL in Q1 2022 and has held it in 17 quarters since. The position peaked at $782K in Q4 2025. 1,640 funds tracked by Wall St. Rank hold QUAL as of Q1 2026.

  • NCM Capital Management held 3,939 shares of iShares MSCI USA Quality Factor ETF worth $756K as of Q1 2026.
  • NCM Capital Management left its iShares MSCI USA Quality Factor ETF share count unchanged in Q1 2026.
  • iShares MSCI USA Quality Factor ETF made up 0.27% of NCM Capital Management's portfolio in Q1 2026, its #89 holding.
  • NCM Capital Management first reported a position in iShares MSCI USA Quality Factor ETF in Q1 2022 and has held it in 17 quarters since.
  • NCM Capital Management's iShares MSCI USA Quality Factor ETF position peaked at $782K in Q4 2025.
  • 1,640 funds tracked by Wall St. Rank held iShares MSCI USA Quality Factor ETF as of Q1 2026.

Based on NCM Capital Management's 13F filing for Q1 2026, filed 15 May 2026.